当前位置:首页>产品中心>单抗/多抗>Anti-Human 4-1BB/TNFRSF9/CD137& HER2 Bispecific Reference Antibody|抗人4-1BB/TNFRSF9/CD137和HER2双特异性参考抗体(靶标:人4-1BB/HER2)

Anti-Human 4-1BB/TNFRSF9/CD137& HER2 Bispecific Reference Antibody|抗人4-1BB/TNFRSF9/CD137和HER2双特异性参考抗体(靶标:人4-1BB/HER2)

  • 货号:RB9THC336186
  • 价格:面议
  • 点击:193

产品介绍

产品参数

形态Liquid
宿主种属Human
抗体亚型IgG
纯度>95% purity as determined by SDS-PAGE.
纯化方式Protein A/G purified from cell culture supernatant.
浓度1mg/ml
内毒素水平Please contact the lab for this information.
应用ELISA, Bioactivity: FACS, Functional assay, Research in vivo
种属反应性Human
靶标Bispecific, Tumor necrosis factor receptor superfamily member 9, CD137, 4-1BB ligand receptor, CDw137, TNFRSF9, T-cell antigen ILA, T-cell antigen 4-1BB homolog, ILA, p185erbB2, HER2, NGL, Tyrosine ki
储存缓冲液0.01M PBS, pH 7.4.
稳定性和储存Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
表达系统Mammalian Cells
登录号Q07011 & P04626
背景信息Cinrebafusp alfa (PRS 343) is a high affinity CD137/HER2 bispecfic anticalin-based drug. Cinrebafusp alfa binds to recombinant human HER2 (Kd=0.3 nM) and human monomeric CD137 (4-1BB; Kd=5 nM). Cinrebafusp alfa facilitates T-cell costimulation by tumor-localized, HER2-dependent 4-1BB clustering and activation, further enhancing T-cell receptor-mediated activity and leading to tumor destruction. Cinrebafusp alfa has the potential for HER2+ solid tumors research.
备注For research use only. Not suitable for clinical or therapeutic use.
【仅供科学研究使用】

相关产品:
总计 33037 个记录,共 1652 页,当前第 1 页 | 第一页 上一页 下一页 最末页
在线客服
  • 销售热线:
  • 15898894496(同微信)
  • 我要留言
  • 周一至周五每天9:00-17:00